RxDoctor Payments Data

Jerry Gibbons, MD

Psychiatry · Rolling Meadows, ILNPI 1619080124

Payments from drug & device makers

$4,832in general payments, 2019–2025

Across 237 payments — averaging $20.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$742
  • Neurocrine Biosciences, Inc.$719
  • AbbVie$706
  • Sunovion Pharmaceuticals Inc.$477
  • Lundbeck LLC$405
  • Vanda Pharmaceuticals Inc.$396
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$4,65696%
  • Education$1754%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,832 in reported general payments places this provider in the 85th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$54,102
Medicare patients
124
Services billed
509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate24$86,141
RexultiBrexpiprazole34$53,944
VraylarCariprazine Hcl26$40,144
Lurasidone Hcl75$32,818
CaplytaLumateperone Tosylate11$17,592
Clozapine195$16,451
Aripiprazole163$14,951
Risperidone ErRisperidone Microspheres17$13,436
Risperdal ConstaRisperidone Microspheres12$9,528
Quetiapine Fumarate361$7,498
TrintellixVortioxetine Hydrobromide13$6,081
Bupropion XlBupropion Hcl317$5,803
Olanzapine178$5,490
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate13$5,297
Alprazolam453$5,247

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$204$95,66936 claims
Otsuka America Pharmaceutical, Inc.Rexulti$212$53,94434 claims
AbbVieVraylar$706$40,14426 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$742$17,59211 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$35$6,08113 claims
Almatica Pharma LLCSertraline Hcl$17$1,282178 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Rolling Meadows

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →